The India biosimilar market is undergoing rapid transformation, driven by the increasing prevalence of chronic diseases, growing healthcare expenditure, and the rising demand for affordable biologic therapies. Biosimilars — which are highly similar, safe, and effective versions of original biologic drugs — are revolutionizing healthcare accessibility in India by offering...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek